About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
University Department of Clinical Oncology
›
top-articles
University Department of Clinical Oncology
37
(top 2%)
papers
1.0K
(top 2%)
citations
20
(top 1%)
h
-index
32
(top 2%)
g
-index
37
all documents
1.0K
doc citations
388
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response
Cancer Chemotherapy and Pharmacology
1989
144
2
Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study
British Journal of Cancer
1993
100
3
Intermittent high-dose tamoxifen as a potential modifier of multidrug resistance
European Journal of Cancer
1992
66
4
The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin.
BMJ: British Medical Journal
1988
57
5
Glutathione and related enzyme activity in human lung cancer cell lines
British Journal of Cancer
1988
56
6
Zoladex: Endocrine and therapeutic effects in post-menopausal breast cancer
British Journal of Cancer
1989
49
7
Arginine vasopressin – a mediator of chemotherapy induced emesis?
British Journal of Cancer
1989
43
8
Allergic reactions to carboplatin
Annals of Oncology
1992
43
9
Phase II study of the antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717) in advanced breast cancer
European Journal of Cancer & Clinical Oncology
1988
41
10
Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer
British Journal of Cancer
2001
39
11
The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16–213, doxorubicin and vincristine (VPAV) for small cell lung cancer
European Journal of Cancer & Clinical Oncology
1988
35
12
A phase II trial of ifosfamide/mesna with doxorubicin for malignant mesothelioma
European Journal of Cancer & Clinical Oncology
1989
30
13
A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancer
British Journal of Cancer
1992
27
14
High-Dose (480 mg/day) Tamoxifen with Etoposide: A Study of a Potential Multi-Drug Resistance Modulator
Oncology
1994
26
15
BACK PAIN—A PRESENTATION OF METASTATIC TESTICULAR GERM CELL TUMOURS
Lancet, The
1987
23
16
Phase II study of doxorubicin plus ifosfamide/mesna in patients with advanced breast cancer
Cancer
1990
23
17
Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancer
Cancer Chemotherapy and Pharmacology
1995
23
18
A phase II study of the platinum analogues JM8 and JM9 in malignant pleural mesothelioma
Cancer Chemotherapy and Pharmacology
1986
21
19
A phase II study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcoma
Cancer Chemotherapy and Pharmacology
1988
21
20
Verapamil with mitoxantrone for advanced ovarian cancer: A negative phase II trial
Annals of Oncology
1991
21
21
Intravenous infusions of ifosfamide/mesna and perturbation of warfarin anticoagulant control.
Postgraduate Medical Journal
1990
17
22
Single high-dose (45 mg) infusions of aminohydroxypropylidene diphosphonate for severe malignant hypercalcemia
Cancer
1989
15
23
Gynaecomastia and extragonadal symptoms leading to diagnosis delay of germ cell tumours in young men.
Postgraduate Medical Journal
1991
15
24
Phase II study of low dose aminoglutethimide 250 mg/day plus hydrocortisone in advanced postmenopausal breast cancer
European Journal of Cancer & Clinical Oncology
1989
14
25
Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481)
European Journal of Cancer
1995
14
26
Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer
British Journal of Cancer
1991
13
27
Thromboses and thromboemboli in patients with lymphoma during cytotoxic chemotherapy.
BMJ: British Medical Journal
1988
12
28
Zoladex: Therapeutic Effects in Postmenopausal Breast Cancer
Hormone Research
1989
9
29
Cisplatin with high-dose infusions of hydroxyurea to inhibit DNA repair
Cancer Chemotherapy and Pharmacology
1989
9
30
Metastatic Breast Cancer Presenting with Diabetes Insipidus
Acta Oncológica
1992
7
31
The efficacy of 5-fluorouracil in human colorectal cancer is not enhanced by thymidylate synthetase inhibition with CB3717 (N10-propargyl-5,8 dideazafolic acid)
British Journal of Cancer
1988
6
32
Results of chemotherapy using ifosfamide with doxorubicin in advanced breast cancer
Breast Cancer Research and Treatment
1994
4
33
Experience with 24-h infusions of ifosfamide/mesna in small cell lung cancer
Cancer Chemotherapy and Pharmacology
1986
3
34
Fixed dose short course mitomyucin C with vincristine in advanced pre-treated breast cancer
Annals of Oncology
1990
3
35
Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancer
Cancer Chemotherapy and Pharmacology
1995
1
36
Reversal of Duodenal Obstruction due to Metastatic Teratoma by Combination Chemotherapy
British Journal of Urology
1989
0
37
Assessment of renal toxicity by urinary enzymes in patients receiving chemotherapy with 8-methyl-8-acetylenic-putrescine
Cancer Chemotherapy and Pharmacology
1990
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.